• |

Sep. 24, 2014

Analyzing GSK’s Record-Breaking Chinese Bribery Fine

  • Rebecca Hughes Parker and Nicole Di Schino
    Anti-Corruption Report
China has fined GlaxoSmithKline a record 3 billion yuan ($489 million) for paying bribes to hospitals and doctors to prescribe its products, closing a fifteen-month investigation into the company’s activities there.  FCPA experts shared insights with the Anti-Corruption Report about the impact of the historic decision on GSK and other multi-national companies operating in China.  See also “Seven Lessons from China’s Bribery Investigation of GlaxoSmithKline” (Aug. 7, 2013).

To read the full article

Continue reading your article with an ACR subscription.

Most-Read Articles

Spotlight on Trailblazing Women

To mark International Women’s Day 2024, women editors and reporters of ION Analytics interviewed outstanding women in the industries and jurisdictions we cover. In this part, Jill Abitbol, Managing Editor of the Cybersecurity Law Report and Anti-Corruption Report, features notable women in data privacy, cybersecurity, white collar defense, compliance and anti-corruption law, including Christina Montgomery, Leslie Shanklin, Palmina Fava, Alexandra Ross and Lucinda Low. Enjoy reading their inspiring remarks here.